ACE and Ventriculomegaly: Contractility is consistently impaired in patients with HFmrEF paralleling the degree of ventricular dilatation suggesting that drugs targeting the ventricular remodeling such as angiotensin converting enzyme inhibitors, Spironolactone or β-blockers maintain their beneficial effects in this group of patients still insufficiently characterized38.